O36.1111 Maternal care for Anti-A sensitization, first trimester, fetus 1

Name of the Condition

• Maternal care for Anti-A sensitization, first trimester, fetus 1
• ICD Code: O36.1111

Summary

This condition involves medical care and monitoring provided to a pregnant woman with anti-A sensitization during the first trimester, specifically for a singleton pregnancy. The care focuses on managing potential risks to the fetus and ensuring maternal health, particularly addressing the risk of hemolytic disease of the fetus and newborn (HDFN).

Causes

Anti-A sensitization occurs when an individual with type O blood is exposed to A or AB blood, triggering the production of anti-A antibodies. In pregnancy, this exposure may happen if the fetus has A or AB blood type, and fetal-maternal blood mixing occurs, leading the mother's immune system to produce antibodies that may cross the placenta and affect the fetus.

Risk Factors

• Previous pregnancy with an A or AB blood type fetus
• Blood transfusion with A or AB blood
• Abdominal trauma during pregnancy
• Invasive prenatal procedures (e.g., chorionic villus sampling)
• Prior miscarriage or ectopic pregnancy involving an A or AB blood type fetus

Symptoms

• Often asymptomatic in the mother
• Fetal anemia, jaundice, or hydrops fetalis in severe cases
• Elevated bilirubin levels in the newborn (if born)

Diagnosis

Blood typing and antibody screening to detect anti-A antibodies. Doppler ultrasound to assess fetal blood flow and anemia. Amniocentesis or cordocentesis may be used to evaluate fetal blood status.

Treatment Options

• Close monitoring of maternal antibody levels
• Regular fetal ultrasounds to assess growth and well-being
• Possible intrauterine transfusions if severe anemia is detected
• Planning for delivery timing and neonatal care

Prognosis and Follow-Up

With proper monitoring and intervention, outcomes are generally favorable. Follow-up includes continued fetal surveillance and postnatal monitoring of the newborn for signs of anemia or jaundice.

Complications

• Severe fetal anemia
• Hydrops fetalis (fluid accumulation in fetal tissues)
• Kernicterus (brain damage from bilirubin buildup)
• Increased risk of preterm birth

Lifestyle & Prevention

• Avoid unnecessary blood transfusions with incompatible blood types
• Use precautions during invasive prenatal procedures to minimize fetal-maternal blood mixing
• Early prenatal care to detect sensitization early

When to Seek Professional Help

• Unusual fetal movement changes
• Signs of maternal infection or bleeding
• Concerns about fetal well-being during routine check-ups

Tips for Medical Coders

Document the trimester (first) and number of fetuses (singleton) clearly. Ensure the anti-A sensitization is confirmed via laboratory testing and that care provided aligns with monitoring and management of HDFN risk.